103 related articles for article (PubMed ID: 27172740)
1. Study on the relationship between the structure and functions of anti-human cervical cancer single-chain antibody and the lengths of linkers.
Cheng J; Dul Qx; Zhang ; Ren Yf; Zhang Ba; Feng Xd
Eur J Gynaecol Oncol; 2016; 37(2):171-7. PubMed ID: 27172740
[TBL] [Abstract][Full Text] [Related]
2. Optimization modeling of single-chain antibody against hepatoma based on similarity algorithm.
Zhao ZJ; Chen JT; Yuan JY; Yin XX; Song HY; Wang XC
Int J Clin Exp Med; 2015; 8(9):14827-36. PubMed ID: 26628964
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the structure of anti-human seminal plasma protein single-chain antibody and its association with linker peptide length.
Jiang X; Zhai J; Song D; Qu Q; Li M; Xing L; Miao S
Mol Med Rep; 2015 Sep; 12(3):4117-4122. PubMed ID: 26099852
[TBL] [Abstract][Full Text] [Related]
4. The effect of varying the peptide linker length in a single chain variable fragment antibody against wogonin glucuronide.
Paudel MK; Sakamoto S; Van Huy L; Tanaka H; Miyamoto T; Morimoto S
J Biotechnol; 2017 Jun; 251():47-52. PubMed ID: 28392422
[TBL] [Abstract][Full Text] [Related]
5. Enhancement and Analysis of Human Antiaflatoxin B1 (AFB1) scFv Antibody-Ligand Interaction Using Chain Shuffling.
Rangnoi K; Choowongkomon K; O'Kennedy R; Rüker F; Yamabhai M
J Agric Food Chem; 2018 Jun; 66(22):5713-5722. PubMed ID: 29781609
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the relationship between end-to-end distance and activity of single-chain antibody against colorectal carcinoma.
Zhang J; Liu S; Shang Z; Shi L; Yun J
Theor Biol Med Model; 2012 Aug; 9():38. PubMed ID: 22913623
[TBL] [Abstract][Full Text] [Related]
7. An unusual cysteine V
Attallah C; Aguilar MF; Garay AS; Herrera FE; Etcheverrigaray M; Oggero M; Rodrigues DE
Mol Immunol; 2017 Oct; 90():143-149. PubMed ID: 28755586
[TBL] [Abstract][Full Text] [Related]
8. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
9. Insilico analysis of three different tag polypeptides with dual roles in scFv antibodies.
Mohammadi M; Nejatollahi F; Sakhteman A; Zarei N
J Theor Biol; 2016 Aug; 402():100-6. PubMed ID: 27113782
[TBL] [Abstract][Full Text] [Related]
10. Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study.
Wang T; Duan Y
Protein Eng Des Sel; 2011 Sep; 24(9):649-57. PubMed ID: 21729946
[TBL] [Abstract][Full Text] [Related]
11. [Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].
Chen Y; Guo J; Yin Y; Jiang M; Zhu H; Zhang G; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):960-3. PubMed ID: 25200159
[TBL] [Abstract][Full Text] [Related]
12. Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions.
Yamauchi S; Kobashigawa Y; Fukuda N; Teramoto M; Toyota Y; Liu C; Ikeguchi Y; Sato T; Sato Y; Kimura H; Masuda T; Ohtsuki S; Noi K; Ogura T; Morioka H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323851
[TBL] [Abstract][Full Text] [Related]
13. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli.
Babaei A; Zarkesh-Esfahani SH; Gharagozloo M
J Microbiol Biotechnol; 2011 May; 21(5):529-35. PubMed ID: 21617352
[TBL] [Abstract][Full Text] [Related]
14. Single-chain variable fragment antibody against human aspartyl/asparaginyl beta-hydroxylase expressed in recombinant Escherichia coli.
Yang H; Wang H; Xue T; Xue XP; Huyan T; Wang W; Song K
Hybridoma (Larchmt); 2011 Feb; 30(1):69-79. PubMed ID: 21466288
[TBL] [Abstract][Full Text] [Related]
15. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
16. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
Li Z; Cheng Y; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
Mol Immunol; 2015 Dec; 68(2 Pt A):168-75. PubMed ID: 26325475
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and affinity determination of scFv antibody: proper linker peptide enhances its activity.
Gu X; Jia X; Feng J; Shen B; Huang Y; Geng S; Sun Y; Wang Y; Li Y; Long M
Ann Biomed Eng; 2010 Feb; 38(2):537-49. PubMed ID: 19816775
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Identification of a Single-chain Variable Fragment Antibody Against Canine Distemper Virus.
Yi L; Cheng S
Monoclon Antib Immunodiagn Immunother; 2015 Aug; 34(4):228-32. PubMed ID: 26301925
[TBL] [Abstract][Full Text] [Related]
19. [Construction, structure prediction and phylogenetic analysis of murine scFv gene against human cervical cancer].
Wang Y; Li X; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):723-6. PubMed ID: 16256035
[TBL] [Abstract][Full Text] [Related]
20. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
